Monterossi G, Pedone Anchora L, Gueli Alletti S, Fagotti A, Fanfani F, Scambia G
Facts Views Vis Obgyn. 2022 Mar;14(1):91-94. doi: 10.52054/FVVO.14.1.014.
The benefits of minimally invasive surgery are well known in gynaecology. Robotic-assisted surgery has gained widespread acceptance within the surgical community and seems to be the most rapidly developing sector of minimally invasive surgery.
This video shows the salient steps of total hysterectomy with new robotic technology, Hugo™ RAS. The objectives were to introduce and demonstrate the feasibility, efficacy, and safety of this new advanced device.
A sixty-two years-old woman affected by BRCA-1 mutation underwent the first European gynaecological surgical procedure using the new surgical robot Hugo™ RAS in the Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Docking and operative times.
The docking time was 6 minutes and the total operative time was 58 minutes. There were no system errors and faults in the robotic arms. The surgeon found no friction or rasping in the arms. The estimated blood loss was 30 mL. No intraoperative complications were recorded.
Gynaecological surgery with Hugo™ RAS seems feasible, safe and effective as shown by initial experiences in urological surgery. A larger case series would confirm the current experience and determine whether this technology could offer any additional benefit.
微创手术在妇科领域的益处已广为人知。机器人辅助手术已在外科界获得广泛认可,似乎是微创手术中发展最为迅速的领域。
本视频展示了使用新型机器人技术Hugo™ RAS进行全子宫切除术的关键步骤。目的是介绍并演示这种新型先进设备的可行性、有效性和安全性。
一名62岁的BRCA - 1基因突变女性在意大利罗马的圣心天主教大学综合医院基金会妇产科肿瘤学部接受了首例使用新型手术机器人Hugo™ RAS的欧洲妇科手术。
对接时间和手术时间。
对接时间为6分钟,总手术时间为58分钟。机器人手臂未出现系统错误和故障。外科医生未发现手臂有摩擦或刺耳声。估计失血量为30毫升。未记录到术中并发症。
如泌尿外科手术的初步经验所示,使用Hugo™ RAS进行妇科手术似乎可行、安全且有效。更大规模的病例系列将证实当前经验,并确定该技术是否能带来任何额外益处。